BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7629814)

  • 1. Reversible inhibitors of the gastric (H+/K+)-ATPase. 5. Substituted 2,4-diaminoquinazolines and thienopyrimidines.
    Ife RJ; Brown TH; Blurton P; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Theobald CJ
    J Med Chem; 1995 Jul; 38(14):2763-73. PubMed ID: 7629814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent.
    Leach CA; Brown TH; Ife RJ; Keeling DJ; Laing SM; Parsons ME; Price CA; Wiggall KJ
    J Med Chem; 1992 May; 35(10):1845-52. PubMed ID: 1316968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
    Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
    J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
    Pope AJ; Boehm MK; Leach C; Ife RJ; Keeling D; Parsons ME
    Biochem Pharmacol; 1995 Nov; 50(10):1543-9. PubMed ID: 7503755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibitors of the gastric (H+/K+)-ATPase. 4. Identification of an inhibitor with an intermediate duration of action.
    Leach CA; Brown TH; Ife RJ; Keeling DJ; Parsons ME; Theobald CJ; Wiggall KJ
    J Med Chem; 1995 Jul; 38(14):2748-62. PubMed ID: 7629813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
    Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
    Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
    Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
    Nishida H; Hasuoka A; Arikawa Y; Kurasawa O; Hirase K; Inatomi N; Hori Y; Sato F; Tarui N; Imanishi A; Kondo M; Takagi T; Kajino M
    Bioorg Med Chem; 2012 Jun; 20(12):3925-38. PubMed ID: 22579619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of N-substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors.
    Yamakawa T; Matsukura H; Nomura Y; Yoshioka M; Masaki M; Igata H; Okabe S
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1746-52. PubMed ID: 1663837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolines.
    Brown TH; Ife RJ; Keeling DJ; Laing SM; Leach CA; Parsons ME; Price CA; Reavill DR; Wiggall KJ
    J Med Chem; 1990 Feb; 33(2):527-33. PubMed ID: 2153816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors.
    Hennequin LF; Thomas AP; Johnstone C; Stokes ES; Plé PA; Lohmann JJ; Ogilvie DJ; Dukes M; Wedge SR; Curwen JO; Kendrew J; Lambert-van der Brempt C
    J Med Chem; 1999 Dec; 42(26):5369-89. PubMed ID: 10639280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase.
    LaMattina JL; McCarthy PA; Reiter LA; Holt WF; Yeh LA
    J Med Chem; 1990 Feb; 33(2):543-52. PubMed ID: 2153817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conformation of an inhibitor bound to the gastric proton pump.
    Middleton DA; Robins R; Feng X; Levitt MH; Spiers ID; Schwalbe CH; Reid DG; Watts A
    FEBS Lett; 1997 Jun; 410(2-3):269-74. PubMed ID: 9237643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K; Nagao T; Urushidani T
    Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gastric H+, K(+)-ATPase by flavonoids: a structure-activity study.
    Murakami S; Muramatsu M; Tomisawa K
    J Enzyme Inhib; 1999; 14(2):151-66. PubMed ID: 10445040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.